Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A procedural framework for good imaging practice in pharmacological fMRI studies applied to drug development #2: protocol optimization and best practices.
Schwarz AJ, Becerra L, Upadhyay J, Anderson J, Baumgartner R, Coimbra A, Evelhoch J, Hargreaves R, Robertson B, Iyengar S, Tauscher J, Bleakman D, Borsook D. Schwarz AJ, et al. Among authors: becerra l. Drug Discov Today. 2011 Aug;16(15-16):671-82. doi: 10.1016/j.drudis.2011.03.011. Epub 2011 Apr 6. Drug Discov Today. 2011. PMID: 21477664 Review.
A role for fMRI in optimizing CNS drug development.
Borsook D, Becerra L, Hargreaves R. Borsook D, et al. Among authors: becerra l. Nat Rev Drug Discov. 2006 May;5(5):411-24. doi: 10.1038/nrd2027. Nat Rev Drug Discov. 2006. PMID: 16604100 Review.
A 'BOLD' experiment in defining the utility of fMRI in drug development.
Borsook D, Bleakman D, Hargreaves R, Upadhyay J, Schmidt KF, Becerra L. Borsook D, et al. Among authors: becerra l. Neuroimage. 2008 Aug 15;42(2):461-6. doi: 10.1016/j.neuroimage.2008.04.268. Epub 2008 Jun 10. Neuroimage. 2008. PMID: 18598770 Review. No abstract available.
A procedural framework for good imaging practice in pharmacological fMRI studies applied to drug development #1: processes and requirements.
Schwarz AJ, Becerra L, Upadhyay J, Anderson J, Baumgartner R, Coimbra A, Evelhoch J, Hargreaves R, Robertson B, Iyengar S, Tauscher J, Bleakman D, Borsook D. Schwarz AJ, et al. Among authors: becerra l. Drug Discov Today. 2011 Jul;16(13-14):583-93. doi: 10.1016/j.drudis.2011.05.006. Epub 2011 May 24. Drug Discov Today. 2011. PMID: 21635967 Review.
238 results